Jump to Navigation
Skip to main content
Give Now
Follow Us on Twitter
Follow Us on Instagram
Watch us on YouTube
Follow Us on LinkedIn
Subscribe to our email list
UCLA Stemcell RSS Feed
Search form
Search
Eli and Edythe Broad Center of
Regenerative Medicine and Stem Cell Research
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research
About Us
Mission
Milestones
About the Broads
Leadership & Key Members
Stem Cell FAQs & Resources
Contact
Careers
Research & Facilities
Research Areas
Publications
Research Funding
Oversight & Review
Shared Resources & Facilities
Clinical Trials
Alpha Stem Cell Clinic
Current Clinical Trials
Education & Training
Training Programs
Classes & Clubs
Seminars
News, Events, Videos
Newsroom
Event Calendar
Annual Stem Cell Symposium
Videos
Join Us
Give Now
Annual Fund
Innovation Fund
Training Fund
Donor FAQs
Subscribe to Our Emails
Menu
About Us
Mission
Milestones
About the Broads
Leadership & Key Members
Stem Cell FAQs & Resources
Contact
Careers
Research & Facilities
Research Areas
Publications
Research Funding
Oversight & Review
Shared Resources & Facilities
Clinical Trials
Alpha Stem Cell Clinic
Current Clinical Trials
Education & Training
Training Programs
Classes & Clubs
Seminars
News, Events, Videos
Newsroom
Event Calendar
Annual Stem Cell Symposium
Videos
Join Us
Give Now
Annual Fund
Innovation Fund
Training Fund
Donor FAQs
Subscribe to Our Emails
Blood
Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
Read more
about Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
Stem Cell Gene Therapy for Sickle Cell Disease
Read more
about Stem Cell Gene Therapy for Sickle Cell Disease
Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
Read more
about Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
Autologous Transplantation of Bone Marrow CD34+ Stem/Progenitor Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector for Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)
Read more
about Autologous Transplantation of Bone Marrow CD34+ Stem/Progenitor Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector for Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)
A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
Read more
about A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
Efficacy and Safety of Cryopreserved Formulation of Autologous CD34+ Hematopoietic Stem Cells Transduced Ex Vivo With EFS Lentiviral Vector Encoding for Human ADA Gene in Subjects With Severe Combined Immunodeficiency Due to ADA Deficiency
Read more
about Efficacy and Safety of Cryopreserved Formulation of Autologous CD34+ Hematopoietic Stem Cells Transduced Ex Vivo With EFS Lentiviral Vector Encoding for Human ADA Gene in Subjects With Severe Combined Immunodeficiency Due to ADA Deficiency
A Phase 1/2, Open-label, Single-arm Study to Assess the Safety, Tolerability, and Efficacy of ST-400 Autologous Hematopoietic Stem Cell Transplant for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)
Read more
about A Phase 1/2, Open-label, Single-arm Study to Assess the Safety, Tolerability, and Efficacy of ST-400 Autologous Hematopoietic Stem Cell Transplant for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)